VEGF/rGel
/ Targa Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 04, 2024
Light-enhanced VEGF/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment.
(PubMed, Front Immunol)
- "VEGF/rGel-PCI describes a novel concept for ICI enhancement which induces a rapid CD8+ dependent tumor eradication in both CT26 and MC38 tumors. The concept is based on the combination of intracellular ROS generation and vascular targeting using a plant derived toxin and will be developed towards clinical utilization."
Immunogenic cell death • Journal • Colon Cancer • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor • CD8 • HMGB1 • HSP90AA1
September 16, 2018
Light-enhanced VEGF/rGel: A tumor targeted modality with vascular and immune-mediated efficacy.
(PubMed, J Control Release)
- "A 50% complete remission (CR) of CT26.CL25 colon carcinoma allografts was found in immunocompetent mice while no CR was detected in CT26.CL25 bearing athymic mice. In conclusion, the present report indicate VEGF/rGel -PCI as a treatment modality with multimodal tumor targeted efficacy that should be further developed towards clinical utilization."
Clinical • Journal
1 to 2
Of
2
Go to page
1